These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 15923105)

  • 1. Prognostic and predictive value of the thymidylate synthase expression in patients with non-metastatic colorectal cancer.
    Aguiar S; Lopes A; Soares FA; Rossi BM; Ferreira FO; Nakagawa WT; Carvalho AL; Filho WJ
    Eur J Surg Oncol; 2005 Oct; 31(8):863-8. PubMed ID: 15923105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Kornmann M; Schwabe W; Sander S; Kron M; Sträter J; Polat S; Kettner E; Weiser HF; Baumann W; Schramm H; Häusler P; Ott K; Behnke D; Staib L; Beger HG; Link KH
    Clin Cancer Res; 2003 Sep; 9(11):4116-24. PubMed ID: 14519634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significance.
    Yamachika T; Nakanishi H; Inada K; Tsukamoto T; Kato T; Fukushima M; Inoue M; Tatematsu M
    Cancer; 1998 Jan; 82(1):70-7. PubMed ID: 9428481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoural expression of thymidylate synthase is an independent predictor of prognosis in patients with squamous cell carcinoma of the tongue: results from a retrospective study.
    Kawano K; Yanagisawa S; Kusukawa J; Sunagawa H; Shiba R; Goto M; Shinohara M; Fukuda J; Oishi M; Ikemura K; Takahashi T; Sugihara K; Inokuchi T; Mimura T; Goto H
    Int J Oral Maxillofac Surg; 2006 Mar; 35(3):258-64. PubMed ID: 16280240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
    J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy.
    Kamoshida S; Matsuoka H; Ishikawa T; Maeda K; Shimomura R; Inada K; Tsutsumi Y
    Jpn J Clin Oncol; 2004 Oct; 34(10):594-601. PubMed ID: 15591457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymidylate synthase expression predicts the response to 5-fluorouracil-based adjuvant therapy in pancreatic cancer.
    Hu YC; Komorowski RA; Graewin S; Hostetter G; Kallioniemi OP; Pitt HA; Ahrendt SA
    Clin Cancer Res; 2003 Sep; 9(11):4165-71. PubMed ID: 14519641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
    Edler D; Kressner U; Ragnhammar P; Johnston PG; Magnusson I; Glimelius B; Påhlman L; Lindmark G; Blomgren H
    Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer.
    Jensen SA; Vainer B; Witton CJ; Jørgensen JT; Sørensen JB
    Acta Oncol; 2008; 47(6):1054-61. PubMed ID: 18607850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of thymidylate synthase expression in lymph node metastases of colorectal cancer can improve the prognostic information.
    Ohrling K; Edler D; Hallström M; Ragnhammar P; Blomgren H
    J Clin Oncol; 2005 Aug; 23(24):5628-34. PubMed ID: 16009948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer patients treated with 5-FU-based chemotherapy.
    Huang CL; Yokomise H; Kobayashi S; Fukushima M; Hitomi S; Wada H
    Int J Oncol; 2000 Jul; 17(1):47-54. PubMed ID: 10853017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between expression of thymidylate synthase and colorectal carcinoma].
    Yu ZG; Sun JZ; Zhang Q; Jia HY; Wang JX
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1432-5. PubMed ID: 15500737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer.
    Jakob C; Aust DE; Meyer W; Baretton GB; Schwabe W; Häusler P; Becker H; Liersch T
    J Pathol; 2004 Dec; 204(5):562-8. PubMed ID: 15538739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
    Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
    Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymidylate synthase expression in normal colonic mucosa: a predictive marker of toxicity in colorectal cancer patients receiving 5-fluorouracil-based adjuvant chemotherapy.
    Santini D; Vincenzi B; Perrone G; Rabitti C; Borzomati D; Caricato M; La Cesa A; Grilli C; Verzì A; Coppola R; Tonini G
    Oncology; 2004; 67(2):135-42. PubMed ID: 15539918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.
    Ichikawa W; Uetake H; Shirota Y; Yamada H; Nishi N; Nihei Z; Sugihara K; Hirayama R
    Clin Cancer Res; 2003 Feb; 9(2):786-91. PubMed ID: 12576451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor thymidylate synthase 1494del6 genotype as a prognostic factor in colorectal cancer patients receiving fluorouracil-based adjuvant treatment.
    Dotor E; Cuatrecases M; Martínez-Iniesta M; Navarro M; Vilardell F; Guinó E; Pareja L; Figueras A; Molleví DG; Serrano T; de Oca J; Peinado MA; Moreno V; Germà JR; Capellá G; Villanueva A
    J Clin Oncol; 2006 Apr; 24(10):1603-11. PubMed ID: 16575011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of thymidylate synthase in relation to survival and chemosensitivity in gastric cancer patients.
    Tsujitani S; Konishi I; Suzuki K; Oka S; Gomyo Y; Matsumoto S; Hirooka Y; Kaibara N
    J Exp Clin Cancer Res; 2000 Jun; 19(2):189-95. PubMed ID: 10965817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidylate synthase expression: an independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer.
    Edler D; Hallström M; Johnston PG; Magnusson I; Ragnhammar P; Blomgren H
    Clin Cancer Res; 2000 Apr; 6(4):1378-84. PubMed ID: 10778966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.